AstraZeneca LP et al v. Prinston Pharmaceutical Inc. > Summary
Court Case Number 1:15-cv-01057
Filing Date Nov 16, 2015
Court Delaware District Court
Status Unknown
Plaintiff
Defendant
Plaintiff Attorneys
6AstraZeneca
Attorney Name: Michael P. Kelly
McCarter & English
AstraZeneca
Attorney Name: Jill K. MacAlpine
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Ryan P. O'Quinn
Finnegan, Henderson, Farabow, Garrett & Dunner
AstraZeneca
Attorney Name: Daniel M. Silver
McCarter & English
AstraZeneca
Attorney Name: Benjamin A. Smyth
McCarter & English
Defendant Attorneys
5Prinston Pharmaceutical Inc.
Attorney Name: Kelly E. Farnan
Richards, Layton & Finger, P.A.
Prinston Pharmaceutical Inc.
Attorney Name: Steven E. Feldman
Hahn Loeser & Parks
Prinston Pharmaceutical Inc.
Attorney Name: Christine Dealy Haynes
Richards, Layton & Finger, P.A.
Prinston Pharmaceutical Inc.
Attorney Name: Sherry L. Rollo
Hahn Loeser & Parks
Counter Defendant
4Counter Claimant
Cause
35:145 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 08425934 | Pharmaceutical compositions | Apr 23, 2013 |
| 07265124 | Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compound | Sep 4, 2007 |
| 07250419 | Trisubstituted triazolopyrimidines for use in platelet aggregation inhibition | Jul 31, 2007 |
| 06525060 | Triazolo(4,5-d)pyrimidine compounds | Feb 25, 2003 |
| 06251910 | 1,2,3-triazolo[4,5-d]pyrimidines as P2T receptor antagonists | Jun 26, 2001 |
